Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report)’s stock price traded down 5.4% during mid-day trading on Friday . The company traded as low as $4.73 and last traded at $4.77. 939,174 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 2,755,729 shares. The stock had previously closed […]
Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) shares dropped 5.4% on Friday . The stock traded as low as $4.73 and last traded at $4.77. Approximately 939,174 shares were traded during mid-day trading, a decline of 66% from the average daily volume of 2,755,729 shares. The stock had previously closed at $5.04. Analyst Upgrades […]
Needham & Company LLC restated their hold rating on shares of Fate Therapeutics (NASDAQ:FATE – Free Report) in a research report released on Thursday, Benzinga reports. A number of other equities analysts also recently issued reports on FATE. Oppenheimer reissued a market perform rating on shares of Fate Therapeutics in a report on Tuesday, February […]
Form PRE 14A Schrodinger, Inc For: Apr 11 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE – Get Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $6.76, but opened at $6.38. Fate Therapeutics shares last traded at $6.37, with a volume of 169,990 shares trading hands. Analysts Set New Price Targets FATE has been the topic […]